425 related articles for article (PubMed ID: 15894301)
21. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
22. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of the Phadia EliA connective tissue disease screen for less common disease-specific autoantibodies.
Parker JC; Bunn CC
J Clin Pathol; 2011 Jul; 64(7):631-3. PubMed ID: 21220786
[TBL] [Abstract][Full Text] [Related]
24. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
25. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
[TBL] [Abstract][Full Text] [Related]
26. Screening for connective tissue disease-associated antibodies by automated immunoassay.
Willems P; De Langhe E; Claessens J; Westhovens R; Van Hoeyveld E; Poesen K; Vanderschueren S; Blockmans D; Bossuyt X
Clin Chem Lab Med; 2018 May; 56(6):909-918. PubMed ID: 29306915
[TBL] [Abstract][Full Text] [Related]
27. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera.
Copple SS; Martins TB; Masterson C; Joly E; Hill HR
Ann N Y Acad Sci; 2007 Aug; 1109():464-72. PubMed ID: 17785335
[TBL] [Abstract][Full Text] [Related]
28. [Antinuclear antibody screening by an enzyme-linked immunosorbent assay using multiple nuclear antigens].
Iwata H; Aotsuka S; Okawa M; Kinoshita M; Sumiya M
Ryumachi; 1997 Aug; 37(4):548-55. PubMed ID: 9311280
[TBL] [Abstract][Full Text] [Related]
29. Indirect immunofluorescence on HEp-2000 substrate is a sensitive method for detecting anti-Ro/SSA antibodies in patients with lupus erythematosus and/or photosensitivity.
Cozzani E; Drosera M; Siccardi M; Babbini G; Parodi A
J Rheumatol; 2008 Jul; 35(7):1320-2. PubMed ID: 18528967
[TBL] [Abstract][Full Text] [Related]
30. Detection of autoantibodies to nuclear antigens by EIA and IF techniques.
Alem M; Moghadam S; Malki J; Zaidi A; Nayak N; Li TM
Allerg Immunol (Paris); 1997 Sep; 29(7):188, 191-4. PubMed ID: 9373708
[TBL] [Abstract][Full Text] [Related]
31. Comparison of antinuclear antibody profiles obtained using line immunoassay and fluorescence enzyme immunoassay.
Jang J; Kim S; Kim HS; Lee KA; Park J; Park Y
J Int Med Res; 2021 Jun; 49(6):3000605211014390. PubMed ID: 34154430
[TBL] [Abstract][Full Text] [Related]
32. Use of panel testing for detection of antinuclear antibody in a resource-limited setting: an appraisal.
Minz RW; Kumar Y; Saikia B; Anand S; Varma S; Singh S
Postgrad Med; 2016 Nov; 128(8):869-874. PubMed ID: 27494797
[TBL] [Abstract][Full Text] [Related]
33. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?--The routine use of anti-nuclear antibody screening ELISAs.
Sinclair D; Saas M; Williams D; Hart M; Goswami R
Clin Lab; 2007; 53(3-4):183-91. PubMed ID: 17447656
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of Indirect immunofluorescence (IIF) alone as a screening method for antinuclear antibody in connective diseases in India's sub-Himalayan region.
Kalita D; Rekha US; Raj AK; Mahanta P; Gupta P; Deka S
Indian J Pathol Microbiol; 2022; 65(4):873-878. PubMed ID: 36308197
[TBL] [Abstract][Full Text] [Related]
35. Low positive rate of serum autoantibodies in colorectal cancer patients without systemic rheumatic diseases.
Fernández-Suárez A; Muñoz-Colmenero A; Ocaña-Pérez E; Fatela-Cantillo D; Domínguez-Jiménez JL; Díaz-Iglesias JM
Autoimmunity; 2016 Sep; 49(6):383-387. PubMed ID: 27424781
[TBL] [Abstract][Full Text] [Related]
36. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
[TBL] [Abstract][Full Text] [Related]
37. Clinical Performance of Two Automated Immunoassays, EliA CTD Screen and QUANTA Flash CTD Screen Plus, for Antinuclear Antibody Screening.
Yoon S; Moon HW; Kim H; Hur M; Yun YM
Ann Lab Med; 2022 Jan; 42(1):63-70. PubMed ID: 34374350
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the clinical utility of the Elia CTD Screen to indirect immunofluorescence on Hep-2 cells.
Robier C; Amouzadeh-Ghadikolai O; Stettin M; Reicht G
Clin Chem Lab Med; 2016 Aug; 54(8):1365-70. PubMed ID: 26677892
[TBL] [Abstract][Full Text] [Related]
39. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A
J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078
[TBL] [Abstract][Full Text] [Related]
40. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]